INKT
Price
$14.91
Change
-$0.41 (-2.68%)
Updated
Aug 15 closing price
Capitalization
59.43M
SONN
Price
$3.54
Change
-$0.22 (-5.85%)
Updated
Aug 15 closing price
Capitalization
22.18M
Interact to see
Advertisement

INKT vs SONN

Header iconINKT vs SONN Comparison
Open Charts INKT vs SONNBanner chart's image
MiNK Therapeutics
Price$14.91
Change-$0.41 (-2.68%)
Volume$189.21K
Capitalization59.43M
Sonnet BioTherapeutics Holdings
Price$3.54
Change-$0.22 (-5.85%)
Volume$609.46K
Capitalization22.18M
INKT vs SONN Comparison Chart in %
Loading...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INKT vs. SONN commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INKT is a Hold and SONN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (INKT: $14.91 vs. SONN: $3.54)
Brand notoriety: INKT and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INKT: 14% vs. SONN: 11%
Market capitalization -- INKT: $59.43M vs. SONN: $22.18M
INKT [@Biotechnology] is valued at $59.43M. SONN’s [@Biotechnology] market capitalization is $22.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INKT’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • INKT’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, INKT is a better buy in the long-term than SONN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INKT’s TA Score shows that 4 TA indicator(s) are bullish while SONN’s TA Score has 3 bullish TA indicator(s).

  • INKT’s TA Score: 4 bullish, 3 bearish.
  • SONN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, INKT is a better buy in the short-term than SONN.

Price Growth

INKT (@Biotechnology) experienced а +23.63% price change this week, while SONN (@Biotechnology) price change was +9.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INKT($59.4M) has a higher market cap than SONN($22.2M). SONN YTD gains are higher at: 142.466 vs. INKT (113.947). INKT has higher annual earnings (EBITDA): -9.14M vs. SONN (-13.69M). INKT has more cash in the bank: 3.24M vs. SONN (2.06M). SONN has less debt than INKT: SONN (90.4K) vs INKT (5.12M). SONN has higher revenues than INKT: SONN (1M) vs INKT (0).
INKTSONNINKT / SONN
Capitalization59.4M22.2M268%
EBITDA-9.14M-13.69M67%
Gain YTD113.947142.46680%
P/E RatioN/A0.29-
Revenue01M-
Total Cash3.24M2.06M157%
Total Debt5.12M90.4K5,662%
FUNDAMENTALS RATINGS
SONN: Fundamental Ratings
SONN
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INKTSONN
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PSA282.942.05
+0.73%
Public Storage
NGVC38.810.02
+0.05%
Natural Grocers BY Vitamin Cottage
FCCO25.76-0.38
-1.45%
First Community Corp
PJT179.79-3.81
-2.08%
PJT Partners
VCIG0.81-0.04
-5.12%
VCI Global Limited

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-2.68%
RAIN - INKT
44%
Loosely correlated
N/A
LPTX - INKT
42%
Loosely correlated
+10.06%
DARE - INKT
36%
Loosely correlated
+6.28%
SONN - INKT
36%
Loosely correlated
-5.85%
HYPD - INKT
34%
Loosely correlated
+7.62%
More

SONN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONN has been closely correlated with PTHS. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SONN jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-5.85%
PTHS - SONN
70%
Closely correlated
+10.55%
INKT - SONN
36%
Loosely correlated
-2.68%
MBIO - SONN
29%
Poorly correlated
-0.56%
SNBIF - SONN
28%
Poorly correlated
N/A
INBX - SONN
27%
Poorly correlated
-2.55%
More